medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2017-9-80-84medsovet-1959Research ArticleГАСТРОЭНТЕРОЛОГИЯGASTROENTEROLOGYТАКТИКА ПЕДИАТРА ПРИ АБДОМИНАЛЬНОЙ БОЛИ У ДЕТЕЙTACTICS OF PEDITRY IN ABDOMINAL PAIN IN CHILDRENУРСОВАН. И.URSOVAN. I.

д.м.н., профессор

MD, Prof.,

Московский областной научно-исследовательский клинический институт им. М.Ф. ВладимирскогоРоссияMoscow Regional Research and Clinical InstituteRussian Federation201720072017098084Copyright © УРСОВА Н.И., 20172017УРСОВА Н.И.URSOVA N.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/1959

Функциональная абдоминальная боль у детей и подростков характеризуется широчайшим диапазоном проявлений, не относится к отдельной нозологической форме, имеет клиническую, прогностическую значимость и поддерживает интерес интернистов к диагностике и лечению. Учитывая большое разнообразие признаков системности процесса в детском возрасте, целесообразно комплексно обследовать больных с абдоминальной болью. Принципиальное значение для педиатрической практики имеет точный синдромный диагноз, который определяет необходимость и стратегию лечения, при этом тактической задачей врача является выбор препарата с наибольшим терапевтическим и наименьшим токсическим потенциалом.

The functional abdominal pain in children and teenagers is characterized by a wide range of manifestations, doesn’t belong to the separate nosologic form, has clinical, prognostic importance and supports interest of internists to diagnostics and therapy. Taking into account a great variety of signs of the process systemic nature in children it’s reasonable to examine patients with the abdominal pain as a complex. The accurate syndrome diagnosis that determines the necessity and strategy of treatment is of paramount importance for pediatric practice whereas the task of the doctor is the choice of the drug with the maximum therapeutic and minimum toxic potential

детиабдоминальная больтримебутинchildrenabdominal paintrimebutinReferencesНовиков А.В., Яхно Н.Н. Невропатическая боль, патофизиологические механизмы и принципы терапии. РМЖ, 2001, 9(7-8): 318-27.Sperber AD, Drossman DA. Functional Abdominal Pain Syndrome. The American Journal of Gastroenterology, 2010, 105: 770-75.Крыжановский Г.Н. Дисрегуляционная патология. Руководство для врачей и биологов. М.: Медицина, 2002. 38 с.ISAP, Pain: Clinical updates Vol. XX, issue 2 march 2012, Identification and treatment of Neuropathic Pain in patients with cancer http: //www.iosp-pain.org.Beaulieu P, Lussier D, Porreca F, Dickeuson AH. Pharmacology of pain: ISAP Press 2010, 622 p.Beaulieu P, Lussier D, Porreca F, Dickeuson AH. Pharmacology of pain: ISAP Press 2010, 622 p.Drossman DA. The functional Gastrointestinal disorders and the Rome III process. Gastroenterology, 2006, 130(5): 1377-90.Drossman DA. The functional Gastrointestinal disorders and the Rome III process. Gastroenterology, 2006, 130(5): 1377-90.Thompson WG. The road to Rome. Gastroenterology, 2006, 130(5): 1466-79.Thompson WG. The road to Rome. Gastroenterology, 2006, 130(5): 1466-79.Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staino A, van Tilburg M. Childhood functional gastrointestinal disorders: Child/Adolescent. Gastroenterology, 2016, 150(6): 1469-80.Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staino A, van Tilburg M. Childhood functional gastrointestinal disorders: Child/Adolescent. Gastroenterology, 2016, 150(6): 1469-80.Al-Chaer E, Feng Y, Willis WD. Visceral Pain: A disturbance in the sensorimotor continuum? Pain Forum, 1998, 3: 117-125.Al-Chaer E, Feng Y, Willis WD. Visceral Pain: A disturbance in the sensorimotor continuum? Pain Forum, 1998, 3: 117-125.Zeltzer LK, Arnoult S, Hamilton A, DeLaura S. In: Human PE ed. Pediatric Gastrointestinal Motility Disorders. New York: Academy Professional Information Services, 1994: 155-176.Zeltzer LK, Arnoult S, Hamilton A, DeLaura S. In: Human PE ed. Pediatric Gastrointestinal Motility Disorders. New York: Academy Professional Information Services, 1994: 155-176.Cervero F. Mechanisms of Visceral Pain, Past and Present. In: Gebhart GF, eds. Visceral Pain: Progress in Pain Research and Management. Seattle, WA: IASP Press, 1995: 25-40.Cervero F. Mechanisms of Visceral Pain, Past and Present. In: Gebhart GF, eds. Visceral Pain: Progress in Pain Research and Management. Seattle, WA: IASP Press, 1995: 25-40.Devor M. Pain mechanism and pain syndromes. 1996. An Updated Review, IASP Press: 103-12.Devor M. Pain mechanism and pain syndromes. 1996. An Updated Review, IASP Press: 103-12.Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012, 367(17): 1626-35.Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012, 367(17): 1626-35.Gao C, Liu S, Hu HZ, Gao N, Kim GY, Xia Y, Wood JD. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology, 2002, 123: 1554-64.Gao C, Liu S, Hu HZ, Gao N, Kim GY, Xia Y, Wood JD. Serine proteases excite myenteric neurons through protease-activated receptors in guinea pig small intestine. Gastroenterology, 2002, 123: 1554-64.Barbara G, Stanghellini V, DeGiorgio R, Gremon C, Cottrell Gs, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cell in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology, 2004, 12: 693-702.Barbara G, Stanghellini V, DeGiorgio R, Gremon C, Cottrell Gs, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R. Activated mast cell in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology, 2004, 12: 693-702.Barbara G, Wang B, Stanghellini V, Gremon C, Cottrell Gs, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology, 2007, 132: 26-37.Barbara G, Wang B, Stanghellini V, Gremon C, Cottrell Gs, Di Nardo G, Trevisani M, Campi B, Geppetti P, Tonini M, Bunnett NW, Grundy D, Corinaldesi R. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology, 2007, 132: 26-37.Bonaz B. Visceral sensitivity perturbations integrations in the brain-gut axis in functional digestive disorders. J Physiol Pharmacol, 2003, 54(4): 27-42.Bonaz B. Visceral sensitivity perturbations integrations in the brain-gut axis in functional digestive disorders. J Physiol Pharmacol, 2003, 54(4): 27-42.De Zwart IM, de Ross A. MRI for the evalution of gastric physiology. Eur Radiol, 2010, 20: 2609-16.De Zwart IM, de Ross A. MRI for the evalution of gastric physiology. Eur Radiol, 2010, 20: 2609-16.Van Oudenhove L, Coen SJ, Aziz Q. Functional brain imaging of gastrointestinal sensation in health and disease. World J Gastroenterol, 2007, 13(25): 3438-45.Van Oudenhove L, Coen SJ, Aziz Q. Functional brain imaging of gastrointestinal sensation in health and disease. World J Gastroenterol, 2007, 13(25): 3438-45.Irving GA, Wallace MS. Pain Management for the Practicing Physician. New York, NY: Churchill Livingston, 1997.Irving GA, Wallace MS. Pain Management for the Practicing Physician. New York, NY: Churchill Livingston, 1997.Tighe MP, Gummings JR, Afzal NA. Nutrition and inflammatory bowel disease: primary or adjuvant therapy. Curr Opin Clin Nutr Metab Care, 2011, 14(5): 491-96.Tighe MP, Gummings JR, Afzal NA. Nutrition and inflammatory bowel disease: primary or adjuvant therapy. Curr Opin Clin Nutr Metab Care, 2011, 14(5): 491-96.Staudacher YM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet, 2011, 24(5): 487-95.Staudacher YM, Whelan K, Irving PM, Lomer MC. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet, 2011, 24(5): 487-95.Murray K, Wilkinson-Smith V, Hoad C, Costigan C, Cox E, Lam C, Marciani L, Gowland P, Spiller RC. Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Monosaccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI. Am J Gastroenterol, 2014, 109: 11-119.Murray K, Wilkinson-Smith V, Hoad C, Costigan C, Cox E, Lam C, Marciani L, Gowland P, Spiller RC. Differential Effects of FODMAPs (Fermentable Oligo-, Di-, Monosaccharides and Polyols) on Small and Large Intestinal Contents in Healthy Subjects Shown by MRI. Am J Gastroenterol, 2014, 109: 11-119.Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, Fried M, Dai N. Lactose intolerance in irritable bowel syndrome patients with diarrhea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther, 2014, 39(3): 302-311.Yang J, Fox M, Cong Y, Chu H, Zheng X, Long Y, Fried M, Dai N. Lactose intolerance in irritable bowel syndrome patients with diarrhea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity. Aliment Pharmacol Ther, 2014, 39(3): 302-311.Verdu EF. Can gluten contribute to irritable bowel syndrome? Am J Gastroenterol, 2011, 106: 516-18.Verdu EF. Can gluten contribute to irritable bowel syndrome? Am J Gastroenterol, 2011, 106: 516-18.Yoon SL, Grundmann O, Koepp I, Faffell L. Management of irritablebowelsyndrome in adults: conventional and complementary/alternativeapproaches. Altern Med Rev, 2011, 16(2): 134-51.Yoon SL, Grundmann O, Koepp I, Faffell L. Management of irritablebowelsyndrome in adults: conventional and complementary/alternativeapproaches. Altern Med Rev, 2011, 16(2): 134-51.Schang JC, Devroede G, Pilote M. Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. Dis Colon Rectum, 1993, 36(4): 330-36.Schang JC, Devroede G, Pilote M. Effects of trimebutine on colonic function in patients with chronic idiopathic constipation: evidence for the need of a physiologic rather than clinical selection. Dis Colon Rectum, 1993, 36(4): 330-36.Delvaux M., Wingate D. Trimabutine: mechanism of action, effects on gastrointestinal function and clinical results. J Int Med Res, 1997, 25(5): 225-46.Delvaux M., Wingate D. Trimabutine: mechanism of action, effects on gastrointestinal function and clinical results. J Int Med Res, 1997, 25(5): 225-46.Walters JM, Crean P, McCarthy CF. Trimebutine, a new antispasmodic in the treatment of dyspepsia. Ir Med J, 1980, 73(10): 380-81.Walters JM, Crean P, McCarthy CF. Trimebutine, a new antispasmodic in the treatment of dyspepsia. Ir Med J, 1980, 73(10): 380-81.Kountouras J. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepatogastroenterology, 2002, 49(43): 193-97.Kountouras J. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepatogastroenterology, 2002, 49(43): 193-97.Dupon C. Effect du Trimebutine dans les colopathies fonctionnelles de l’enfant. Medicine Enfance, 1982, 2: 6.Dupon C. Effect du Trimebutine dans les colopathies fonctionnelles de l’enfant. Medicine Enfance, 1982, 2: 6.Ruepert T, Quartero A, de Wit N, van der Heijden GJ, Rubin G, Muris JWM. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev, 2011, 8: CD003460.Ruepert T, Quartero A, de Wit N, van der Heijden GJ, Rubin G, Muris JWM. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev, 2011, 8: CD003460.

The authors declare that there are no conflicts of interest present.